Chandrasena Gillian 4

What Happened
Gillian Chandrasena, Senior Vice President and Chief Human Resources Officer of MiniMed Group, received a total of 129,765 restricted stock units (RSUs) on March 11, 2026. These RSUs were issued upon conversion of previously held Medtronic restricted and performance awards as part of MiniMed’s separation from Medtronic. No per-share price or immediate cash value is reported (price listed as N/A); the awards vest on various dates between 2026 and 2028 under MiniMed’s 2026 Long Term Incentive Plan.

Key Details

• Transaction date: March 11, 2026; Form 4 filed March 13, 2026 (timely filing).
• Total RSUs granted/converted: 129,765 shares (comprised of multiple converted awards).
• Price: N/A (conversion, not an open-market purchase or sale).
• Vesting: Awards vest on different schedules — some in three equal installments (July 28, 2026/2027/2028), some in two installments (March 3, 2027/2028), and some on single dates in 2027 or 2028 (per filing).
• Conversion basis: RSUs were converted from Medtronic awards pursuant to the Employee Matters Agreement, using average Medtronic and MMED stock prices around the separation dates.
• Shares after transaction: Not disclosed in this Form 4.
• Transaction code: A = Award/Grant. No 10b5-1 plan, tax-withholding, or late-filing flags disclosed.

Context
These grants are a conversion of legacy Medtronic equity into MiniMed RSUs as part of the corporate separation, not a market purchase or sale by the insider. Converted RSUs typically vest over time and do not necessarily indicate immediate buying or selling intent by the insider. For retail investors, such awards are routine in spin-offs and reflect compensation/retention arrangements rather than an immediate bullish or bearish trading signal.